Page last updated: 2024-08-23

captopril and erythrosine

captopril has been researched along with erythrosine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engler, CB; Larsen, M; Lund-Andersen, H; Mathiesen, ER; Parving, HH1
Hommel, E; Larsen, M; Lund-Andersen, H; Parving, HH2
Molteni, A; Taylor, JM; Ward, WF; Waters, CM1
Higgins, RD; Tadesse, M; Yan, Y; Yossuck, P1
Erinola, M; Tepel, M; van der Giet, M; Zidek, W1

Trials

2 trial(s) available for captopril and erythrosine

ArticleYear
Blood-retina barrier permeability in diabetes during acute ACE-inhibition.
    Acta ophthalmologica, 1991, Volume: 69, Issue:5

    Topics: Adult; Albuminuria; Blood-Retinal Barrier; Captopril; Cell Membrane Permeability; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Double-Blind Method; Female; Fluorescein; Fluorescein Angiography; Fluoresceins; Fluorophotometry; Humans; Hypertension; Male; Middle Aged

1991
Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1990, Volume: 228, Issue:6

    Topics: Adult; Blood Glucose; Blood Pressure; Blood-Retinal Barrier; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fluorescein; Fluoresceins; Hemoglobin C; Humans; Male; Permeability; Prospective Studies

1990

Other Studies

4 other study(ies) available for captopril and erythrosine

ArticleYear
Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy.
    Diabetologia, 1989, Volume: 32, Issue:7

    Topics: Adult; Albuminuria; Bendroflumethiazide; Blood Glucose; Blood Pressure; Blood-Retinal Barrier; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fluorescein; Fluoresceins; Furosemide; Glomerular Filtration Rate; Humans; Male; Middle Aged

1989
Dose-response effects of radiation on the permeability of endothelial cells in culture.
    Radiation research, 1996, Volume: 146, Issue:3

    Topics: Actins; Animals; Captopril; Catalase; Cattle; Cell Membrane Permeability; Cells, Cultured; Cesium Radioisotopes; Cytoskeleton; Dose-Response Relationship, Radiation; Endothelium, Vascular; Fluorescein; Fluoresceins; Gamma Rays; Kinetics; L-Lactate Dehydrogenase; Pulmonary Artery; Time Factors; Vitamin B 12

1996
Captopril improves retinal neovascularization via endothelin-1.
    Investigative ophthalmology & visual science, 2001, Volume: 42, Issue:8

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dextrans; Endothelin-1; Fluorescein Angiography; Fluoresceins; Fundus Oculi; Hyperoxia; Mice; Mice, Inbred C57BL; Perfusion; Retinal Neovascularization; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2001
Captopril and quinapril reduce reactive oxygen species.
    European journal of clinical investigation, 2002, Volume: 32, Issue:10

    Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cells, Cultured; Dose-Response Relationship, Drug; Enalaprilat; Fluoresceins; Fluorescent Dyes; Humans; Isoquinolines; Leukocytes, Mononuclear; Lisinopril; NADPH Oxidases; Quinapril; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Tetrahydroisoquinolines

2002